Population Pharmacokinetic Analysis and Exploratory Exposure–Bleeding Rate Relationship of Emicizumab in Adult and Pediatric Persons with Hemophilia A
Retout, Sylvie, Schmitt, Christophe, Petry, Claire, Mercier, François, Frey, Nicolas
Published in Clinical pharmacokinetics (01.12.2020)
Published in Clinical pharmacokinetics (01.12.2020)
Get full text
Journal Article
Exposure–Bleeding Count Modeling of Emicizumab for the Prophylaxis of Bleeding in Persons with Hemophilia A with/Without Inhibitors Against Factor VIII
Jonsson, Fredrik, Schmitt, Christophe, Petry, Claire, Mercier, Francois, Frey, Nicolas, Retout, Sylvie
Published in Clinical pharmacokinetics (01.07.2021)
Published in Clinical pharmacokinetics (01.07.2021)
Get full text
Journal Article
Ocrelizumab in relapsing and primary progressive multiple sclerosis: Pharmacokinetic and pharmacodynamic analyses of OPERA I, OPERA II and ORATORIO
Gibiansky, Ekaterina, Petry, Claire, Mercier, Francois, Günther, Andreas, Herman, Ann, Kappos, Ludwig, Hauser, Stephen, Yamamoto, Yumi, Wang, Qing, Model, Fabian, Kletzl, Heidemarie
Published in British journal of clinical pharmacology (01.06.2021)
Published in British journal of clinical pharmacology (01.06.2021)
Get full text
Journal Article
Pharmacokinetics and Pharmacodynamics of Emicizumab in Persons with Hemophilia A with Factor VIII Inhibitors: HAVEN 1 Study
Schmitt, Christophe, Adamkewicz, Joanne I., Xu, Jin, Petry, Claire, Catalani, Olivier, Young, Guy, Negrier, Claude, Callaghan, Michael U., Levy, Gallia G.
Published in Thrombosis and haemostasis (01.03.2021)
Published in Thrombosis and haemostasis (01.03.2021)
Get full text
Journal Article
A Model‐Based Framework to Inform the Dose Selection and Study Design of Emicizumab for Pediatric Patients With Hemophilia A
Yoneyama, Koichiro, Schmitt, Christophe, Chang, Tiffany, Dhalluin, Christophe, Nagami, Sayaka, Petry, Claire, Levy, Gallia G.
Published in Journal of clinical pharmacology (01.02.2022)
Published in Journal of clinical pharmacology (01.02.2022)
Get full text
Journal Article
Low immunogenicity of emicizumab in persons with haemophilia A
Schmitt, Christophe, Emrich, Thomas, Chebon, Sammy, Fernandez, Elena, Petry, Claire, Yoneyama, Koichiro, Kiialainen, Anna, Howard, Monet, Niggli, Markus, Paz‐Priel, Ido, Chang, Tiffany
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.11.2021)
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.11.2021)
Get full text
Journal Article
Contribution of Idasanutlin Exposure to Safety, Pharmacodynamics and Clinical Response of Patients with Acute Myeloid Leukemia Treated with Idasanutlin + Cytarabine in Phase I and III Studies
Jamois, Candice, Anders, Doreen, Beckermann, Benjamin M., Genevray, Magali, Mundt, Kirsten, Petry, Claire, Yang, Joy, Kassir, Nastya, Schmitt, Christophe
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Emicizumab dose up‐titration in case of suboptimal bleeding control in people with haemophilia A
Schmitt, Christophe, Mancuso, Maria Elisa, Chang, Tiffany, Podolak‐Dawidziak, Maria, Petry, Claire, Sidonio Jr, Robert, Yoneyama, Koichiro, Key, Nigel S., Niggli, Markus, Lehle, Michaela, Peyvandi, Flora, Oldenburg, Johannes
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.01.2023)
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.01.2023)
Get full text
Journal Article
Phase I study of daily and weekly regimens of the orally administered MDM2 antagonist idasanutlin in patients with advanced tumors
Italiano, Antoine, Miller, Wilson H., Blay, Jean-Yves, Gietema, Jourik A., Bang, Yung-Jue, Mileshkin, Linda R., Hirte, Hal W., Higgins, Brian, Blotner, Steven, Nichols, Gwen L., Chen, Lin Chi, Petry, Claire, Yang, Qi Joy, Schmitt, Christophe, Jamois, Candice, Siu, Lillian L.
Published in Investigational new drugs (01.12.2021)
Published in Investigational new drugs (01.12.2021)
Get full text
Journal Article
Association of Higher Ocrelizumab Exposure With Reduced Disability Progression in Multiple Sclerosis
Hauser, Stephen L., Bar-Or, Amit, Weber, Martin S., Kletzl, Heidemarie, Günther, Andreas, Manfrini, Marianna, Model, Fabian, Mercier, Francois, Petry, Claire, Wing, Qing, Koendgen, Harold, Smith, Terence, Kappos, Ludwig
Published in Neurology : neuroimmunology & neuroinflammation (01.03.2023)
Published in Neurology : neuroimmunology & neuroinflammation (01.03.2023)
Get full text
Journal Article
Evaluation of the Pharmacokinetics, Pharmacodynamics, and Safety of a Single Dose of Emicizumab in Healthy Chinese Subjects
Li, Haiyan, Zhang, Weijiang, Petry, Claire, Li, Lindong, Fernandez, Elena, Kiialainen, Anna, Feng, Sheng, Hsu, Wanling, Li, Li, Wei, Yudong, Schmitt, Christophe
Published in Clinical pharmacology in drug development (01.01.2021)
Published in Clinical pharmacology in drug development (01.01.2021)
Get full text
Journal Article
Pharmacokinetics and coagulation biomarkers in children and adults with hemophilia A receiving emicizumab prophylaxis every 1, 2, or 4 weeks
Kiialainen, Anna, Adamkewicz, Joanne I., Petry, Claire, Oldenburg, Johannes, Pipe, Steven W., Young, Guy, Mahlangu, Johnny, Lehle, Michaela, Niggli, Markus, Castaman, Giancarlo, Jiménez-Yuste, Víctor, Shima, Midori, Négrier, Claude, Schmitt, Christophe
Published in Research and practice in thrombosis and haemostasis (01.01.2024)
Published in Research and practice in thrombosis and haemostasis (01.01.2024)
Get full text
Journal Article